Companies have claimed improvements to yield, batch consistency and output while acknowledging the risks and challenges ...

Sanofi (NASDAQ: SNY) is one of the Most Undervalued International Stocks According to Analysts. On August 14, Sanofi ...

On August 22, Ryan Detrick, Carson Group chief market strategist, joined CNBC for an interview to discuss the bull market run ...

It's called Recursion OS. Using 36 petabytes (36 million gigabytes) of biological and chemical data, Recursion OS can ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Intervention/Treatment: The study tests the drug Dupilumab, administered subcutaneously, alongside a non-sedative antihistamine and a moisturizer. Dupilumab is designed to reduce inflammation and ...

Patients with chronic rhinosinusitis with nasal polyps show high treatment persistence with dupilumab, with a substantial proportion restarting therapy after discontinuation.

The United States Pharmaceutical Market is projected to reach $979.25 billion by 2033, from $638.86 billion in 2024, at a CAGR of 4.86% (2025-2033). Growth is driven by rising chronic diseases ...

Sanofi completes the acquisition of Vigil Neuroscience, Inc. Paris, August 6, 2025. Sanofi announces the completion of its acquisition of Vigil Neuroscience, Inc. (“Vigil”). This acquisition ...